Michael E. Sturmer - 04 Mar 2024 Form 4 Insider Report for Progyny, Inc. (PGNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Apr 2024, 17:23:08 UTC
Prior SEC filing
05 Mar 2024
Next SEC filing
02 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Michael E. Sturmer filed Form 4 for Progyny, Inc. (PGNY) on 03 Apr 2024.

Key facts

  • This page summarizes Michael E. Sturmer's Form 4 filing for Progyny, Inc. (PGNY).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Apr 2024, 17:23.

Change

  • Previous filing in this sequence was filed on 05 Mar 2024.
  • Current net transaction value: -$240,452.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
$0
Shares
+250,000
Change %
+177%
Price
$0.000000
Shares after
390,948
Date
04 Mar 2024
Ownership
Direct
Footnotes
F1
PGNY transaction

Common Stock

Sale

Transaction value
$169,764
Shares
-4,515
Change %
-1.2%
Price
$37.60
Shares after
386,433
Date
01 Apr 2024
Ownership
Direct
Footnotes
F2
PGNY transaction

Common Stock

Sale

Transaction value
$70,688
Shares
-1,880
Change %
-0.49%
Price
$37.60
Shares after
384,553
Date
01 Apr 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+600,000
Change %
Price
$0.000000
Shares after
600,000
Date
04 Mar 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
600,000
Exercise price
$35.48
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F2

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 31, 2023.

Footnote F3

Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .